CH

Metriopharm Ag

Horizon Europe
Compare
1
Projects
1
Coordinated
0
As Partner
€79,887
Total Budget

Budget Range

Min
€79,887
Average
€79,887
Max
€79,887

Role Distribution

Sector Distribution

Budget by Sector (€)

Projects (1)

C

Novel, orally available immune modulator MP1032 with anti-SARS-CoV-2 and anti-cytokine activity

Health101046182
€79,887